FEATURED COMPANIES
- 10X Genomics
- Bio X Cell
- Cellink
- Fluxion Biosciences
- Lunglife Ai, Inc
- Promocell
- MORE
Cells constitute discrete units of biological function and serve as starting points in a myriad of studies to identify and map many of the basic biochemical and physical processes of life. Cell analysis is important to understand, predict, and ultimately analyze factors that underlie cell health, proliferation, function, and death by using various technologies such as PCR, Sequencing, Microfluidics, Spectrometry, Microscopes, High content analysis and others. All these technologies play a major role in gene, protein and RNA expression analysis of cells, having application in research, diagnosis and therapeutics development. Continuous advancements in technologies significantly revealed the heterogeneity, which will further enhance the cell analysis application.
The cell analysis global market is expected to reach $33,542.0 million by 2027 growing at a mid-single-digit CAGR from 2020 to 2027 due to rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery process, growing focusing on personalized medicine, the introduction of advanced technologies in single-cell analysis and emerging Asia-Pacific market. However, stringent government regulations, lack of skilled personnel to use advanced cell analysis Instruments, and the high cost of some of the instruments are expected to hamper the market growth.
The market for cell analysis is segmented based on technique, product, application, end-user and geography. The cell analysis techniques global market is segmented into PCR, Sequencing, Microfluidics and Microarrays, Spectrometry, Microscopy, Cytometry, High Content Analysis, Electrophoresis and Others. Among the techniques, the PCR segment accounted for the largest revenue in 2020 and is expected to grow at a mid-single-digit CAGR from 2020 to 2027. Microfluidics and Microarrays segment is the fastest-growing segment at a high single-digit CAGR from 2020 to 2027.
The cell analysis products market is mainly segmented into consumables, instruments, software and services. Among these, consumables commanded the largest revenue in 2020 and is expected to grow at a mid-single-digit CAGR from 2020 to 2027. The consumables are further sub-segmented into reagents, assay kits, microplates, cell culture consumables and others. Among the consumables sub-segments, the Reagents held the largest share in 2020 and is expected to grow at a mid-single-digit CAGR from 2020 to 2027. Assay kits is the fastest-growing segment at a mid single-digit CAGR from 2020 to 2027. The software and services market is estimated to be $xx million in 2020 and is expected to grow at a mid single-digit CAGR from 2020 to 2027.
The instrument segment is further classified into cell counters, Cell microarray and microfluidics, liquid handling systems, cytometers, microfluidic devices, high content screening (HCS) systems microplate readers, PCR devices, sequencing instruments, spectrometers, microscopes and others. Among instruments, the PCR instruments commanded the largest share in 2020 and is expected to grow at a low single-digit CAGR from 2020 to 2027. This is attributed to extensive use of PCR (qPCR) use in diagnostics and also advancement in PCR systems, the launch of advanced PCR instruments, automated workflows, increasing approvals of PCR bases assays for medical diagnosis and other applications. Cell Microarrays and Microfluidics is the fastest-growing segment at a mid single-digit CAGR from 2020 to 2027 due to increasing advancements in microfluidic technologies mainly for single-cell analysis applications.
The application market is categorized by processes, by field, and by therapeutic area. In the process of application, the market is segmented into cellular processes, signal transduction pathways, circulating tumor cells, single-cell analysis, epigenetic target analysis, subpopulation characterization, and drug and candidate screening. Cellular process application accounted for the largest revenue in 2020 and is expected to grow at a mid single-digit CAGR from 2020 to 2027 due to increasing cell-based research activities and an increase in funding. The sSingle-cell analysis market is the fastest-growing segment at a high single-digit CAGR from 2020 to 2027 due to increasing advancement in single-cell technologies. By field of application, the market is further segmented into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. Diagnostics held the largest revenue in 2020 and is expected to grow at a mid single-digit CAGR from 2020 to 2027 due to the outbreak of various infectious diseases like influenza, Ebola, COVID-19 in recent years, adoption of early screening, companion diagnostic tests, prenatal screening of genetic diseases, and advancements in analytical tools, etc. Stem cell analysis is the fastest-growing segment at a mid single-digit CAGR from 2020 to 2027 due to increasing government support for stem cell-based research and also increasing approval of stem cell-based therapies. The cell imaging market is further segmented into live-cell imaging which commanded the revenue of $xx million in 2020 and is expected to grow at a mid single-digit CAGR from 2020 to 2027. By therapeutic area, the market is further segmented into cancer research, infectious disease, genetic testing, immunology, and others. The Infectious diseases accounted for the largest revenue in 2020 and is expected to grow at a low single-digit CAGR from 2020 to 2027 due to increasing incidence of infectious disease have raised the utilization of cell analytical technologies in research and as well as diagnosis. Cancer research is the fastest-growing segment at a mid single-digit CAGR from 2020 to 2027.
The end-users market is segmented into hospitals & diagnostic laboratories, academic and research institutes, contract research organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, and others. Hospitals & Diagnostic laboratories generated the largest revenue in 2020 and is expected to grow at a mid single-digit CAGR from 2020 to 2027. Contract Research Organizations is the fastest-growing segment at a mid single-digit CAGR from 2020 to 2027.
By geography, the cell analysis global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and the Middle East & Africa). North America accounted for the largest revenue in 2020 and is expected grow at a mid single-digit CAGR from 2020 to 2027 due to increasing R&D expenditure, increasing funding for - cell-based research, increasing application cell analysis in drug discovery & development, increasing demand for personalized medicine; early disease detection, diagnosis and treatment, increasing focus in developing single-cell analysis technologies for various application in therapeutics, diagnostics and disease research.
The Asia-Pacific is the fastest-growing region in the cell analysis global market at a mid single-digit CAGR from 2020 to 2027 which is attributed to the increased scope for research activities in academic & research institutes, increasing outsourcing, increased incidence of chronic diseases (cancer) and infectious disease, increasing awareness about early screening (cancer) and prenatal test and their adoption in clinical care, increasing government and private investment for - cell-based research and also for the development & expansion single-cell analysis technologies and increasing number startup companies engaged in the development innovative solutions. However, lack of technical expertise, high cost of instruments, lack of skilled labors, and large scale clinical data challenges are some of the restraints for the cell analysis market in the region.
The cell analysis global market is competitive and all the players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), Illumine Inc. (U.S.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and Thermo Fisher Scientific, Inc. (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
North America
- U.S.
- Rest of North America
Europe
- Germany
- Italy
- France
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of APAC
Rest of the World (Row)
- Brazil
- Rest of LATAM
- The Middle East and Africa
FEATURED COMPANIES
- 10X Genomics
- Bio X Cell
- Cellink
- Fluxion Biosciences
- Lunglife Ai, Inc
- Promocell
- MORE
1 Executive Summary
2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown & Data Triangulation
2.6.3 Secondary Sources
2.6.4 Key Data Points from Secondary Sources
2.6.5 Primary Sources
2.6.6 Key Data Points from Primary Sources
2.6.7 Assumptions
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Rising Incidence of Infectious and Non-Infectious Diseases and Demand for Early Detection, Diagnosis & Treatment
3.3.1.2 Increasing Government and Private Funding
3.3.1.3 Increasing Advancements in Cell Imaging Technologies Reduce the Cost and Time Consumption for the Drug Discovery Process
3.3.1.4 Growing Focus on Personalized Medicine
3.3.1.5 Introduction of Advanced Technologies in Single-Cell Analysis
3.3.1.6 Emerging Asia-Pacific Cell Analysis Market
3.3.2 Restraints & Threats
3.3.2.1 Lack of Skilled Personnel to Use Advanced Cell Analysis Instruments
3.3.2.2 Expensive Cell Analysis Instruments
3.3.2.3 Maintaining Consistency, Reproducibility of Assays and Lack of Standardization
3.3.2.4 Stringent Regulatory Framework Limits Advancements in Cellular Analysis Market
3.4 Regulatory Affairs
3.4.1 U.S.
3.4.2 Europe
3.4.3 China
3.4.4 India
3.4.5 Japan
3.5 Funding Scenario
3.6 Cell Analysis – Deals, Acquisitions and New Product Launch
3.6.1 New Product Launch
3.7 Deals and Acquisition
3.8 Technological Advancements
3.8.1 Introduction
3.8.2 Crisper Live Cell Imaging
3.8.3 Single-Cell Multi-Omics
3.8.4 Raman Live Cell Imaging
3.8.5 Droplet-Based Microfluidics in Single-Cell Analysis
3.8.6 Inductively Coupled Plasma Mass Spectrometry in Single-Cell Analysis (Icp-Ms)
3.8.7 Deep Learning and Ai in Microscopy
3.8.8 Intelligent Image-Activated Cell Sorting or Ai-Driven Cell Isolation Technology
3.8.9 Advanced Spatial Technologies in Cell Analysis
3.8.10 Digital Microfluidic Isolation of Single-Cells for -Omics (Disco)
3.9 Porter’s Five Force Analysis
3.9.1 Threat of New Entrants
3.9.2 Threat of Substitutes
3.9.3 Competitive Rivalry
3.9.4 Bargaining Power of Suppliers
3.9.5 Bargaining Power of Buyers
3.10 Market Share Analysis by Major Players
3.10.1 Cell Analysis Global Market Share Analysis
3.10.2 Market Share Analysis by Single-Cell Analysis Major Players
4 Cell Analysis Global Market, by Techniques
4.1 Introduction
4.1.1 PCR (Polymerase Chain Reaction)
4.1.2 Sequencing
4.1.3 Microfluidics and Microarrays
4.1.4 Spectrometry
4.1.5 Microscopy
4.1.6 Cytometry
4.1.7 High Content Screening
4.1.8 Electrophoresis
4.1.9 Others
5 Cell Analysis Global Market, by Products
5.1 Introduction
5.2 Consumables
5.2.1 Assay Kits
5.2.2 Reagents
5.2.3 Microplates
5.2.4 Cell Culture Consumables
5.2.5 Others
5.3 Instruments
5.3.1 Cell Counters
5.3.2 Cell Microarrays and Microfluidics
5.3.3 Liquid Handling Systems
5.3.4 Cytometers
5.3.5 High Content Screening Systems
5.3.6 Microplate Readers
5.3.7 Pcr Instruments
5.3.8 Sequencing Instruments
5.3.9 Spectrometers
5.3.10 Microscopes
5.3.11 Other Instruments
5.4 Software and Services
6 Cell Analysis Global Market, by Application
6.1 Introduction
6.2 Cell Analysis Global Market, by Process of Application
6.2.1 Cellular Processes
6.2.2 Signal Transduction Pathway
6.2.3 Circulating Tumor Cells
6.2.4 Single-Cell Analysis
6.2.5 Epigenetic Target Analysis
6.2.6 Subpopulation Characterization
6.2.7 Drug and Candidate Screening
6.3 Cell Analysis Global Market, by Field of Application
6.3.1 Forensics
6.3.2 Therapeutics
6.3.3 Genomic Analysis
6.3.4 Stem Cell Analysis
6.3.5 Biomarker Research
6.3.6 Cell Imaging
6.3.6.1 Live-Cell Imaging
6.3.7 Diagnostics
6.4 Cell Analysis Global Market, by Therapeutic Area of Applications
6.4.1 Cancer Research
6.4.2 Genetic Testing
6.4.3 Infectious Diseases
6.4.4 Immunology
6.4.5 Others
7 Cell Analysis Global Market, by End-Users
7.1 Introduction
7.2 Hospitals and Diagnostic Laboratories
7.3 Academic & Research Laboratories
7.4 Pharmaceuticals and Biotech Companies
7.5 Contract Research Organisations
7.6 Cell Banks
7.7 Others
8 Regional Market Analysis
8.1 Introduction
8.2 North America
8.2.1 United States of America
8.2.2 Rest of North America
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 Italy
8.3.4 Rest of Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Apac
8.5 Rest of the World
8.5.1 Brazil
8.5.2 Rest of Latin America
8.5.3 Middle East and Africa
9 Competitive Landscape
9.1 Introduction
9.2 New Product Launch
9.3 Approval
9.4 Agreements, Partnerships and Collaborations
9.5 Acquisitions
9.6 Others
10 Major Player Profiles
10.1 Agilent Technologies, Inc.
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Key Developments
10.1.5 Business Strategy
10.1.6 SWOT Analysis
10.2 Becton Dickinson and Company
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Key Developments
10.2.5 Business Strategy
10.2.6 SWOT Analysis
10.3 Bio-Rad Laboratories, Inc
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Key Developments
10.3.5 Business Strategy
10.3.6 SWOT Analysis
10.4 Danaher Corporation
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Key Developments
10.4.5 Business Strategy.
10.4.6 SWOT Analysis
10.5 Illumina, Inc.
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Key Developments
10.5.5 Business Strategy
10.5.6 SWOT Analysis
10.6 Merck Kgaa
10.6.1 Overview
10.6.2 Financials
10.6.3 Product Portfolio
10.6.4 Key Developments
10.6.5 Business Strategy
10.6.6 SWOT Analysis
10.7 Olympus Corporation
10.7.1 Overview
10.7.2 Financials
10.7.3 Product Portfolio
10.7.4 Key Developments
10.7.5 Business Strategy
10.7.6 SWOT Analysis
10.8 Perkinelmer, Inc.
10.8.1 Overview
10.8.2 Financials
10.8.3 Product Portfolio
10.8.4 Key Developments
10.8.5 Business Strategy
10.8.6 SWOT Analysis
10.9 Promega Corporation
10.9.1 Overview
10.9.2 Financials
10.9.3 Product Portfolio
10.9.4 Key Developments
10.9.5 Business Strategy
10.9.6 SWOT Analysis
10.10 Qiagen N.V
10.10.1 Overview
10.10.2 Financials
10.10.3 Product Portfolio
10.10.4 Key Developments
10.10.5 Business Strategy
10.10.6 SWOT Analysis
10.11 Thermo Fisher Scientific, Inc.
10.11.1 Overview
10.11.2 Financials
10.11.3 Product Portfolio
10.11.4 Key Developments
10.11.5 Business Strategy
10.11.6 SWOT Analysis
List of Tables
Table 1 Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 2 Cell Analysis Global Market Revenue, by Technique, (2019-2027) ($Mn)
Table 3 Pcr in Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 4 Sequencing in Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 5 Microfluidics and Microarray in Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 6 Spectrometry in Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 7 Microscopy in Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 8 Cytometry in Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 9 High Content Screening Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 10 Electrophoresis Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 11 Others Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 12 Cell Analysis Global Market Revenue, by Products (2019-2027) ($Mn)
Table 13 Cell Analysis Global Market Revenue, by Consumables (2019-2027) ($Mn)
Table 14 Cell Analysis Consumables Global Market Revenue, by Region (2019-2027) ($Mn)
Table 15 Cell Analysis Assay Kits Global Market Revenue, by Region (2019-2027) ($Mn)
Table 16 Cell Analysis Reagents Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 17 Cell Analysis Microplates Global Market Revenue, by Region (2019-2027) ($Mn)
Table 18 Cell Culture Consumables Global Market Revenue, by Region (2019-2027) ($Mn)
Table 19 Other Consumables Global Market Revenue, by Region (2019-2027) ($Mn)
Table 20 Cell Analysis Global Market Revenue, by Instruments (2019-2027) ($Mn)
Table 21 Cell Analysis Instruments Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 22 Cell Counters Global Market Revenue, by Region (2019-2027) ($Mn)
Table 23 Microarrays and Microfluidics Global Market Revenue, by Region (2019-2027) ($Mn)
Table 24 Liquid Handling Systems Global Market Revenue, by Region (2019-2027) ($Mn)
Table 25 Cytometers Global Market Revenue, by Region (2019-2027) ($Mn)
Table 26 High Content Screening Global Market Revenue, by Region (2019-2027) ($Mn)
Table 27 Microplate Readers Global Market Revenue, by Region (2019-2027) ($Mn)
Table 28 Pcr Instruments Global Market Revenue, by Region (2019-2027) ($Mn)
Table 29 Sequencing Instruments Global Market Revenue, by Region (2019-2027) ($Mn)
Table 30 Spectrometers Instruments Global Market Revenue, by Region (2019-2027) ($Mn)
Table 31 Microscopy Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 32 Other Instruments Global Market Revenue, by Region (2019-2027) ($Mn)
Table 33 Software and Services Global Market Revenue, by Region (2019-2027) ($Mn)
Table 34 Cell Analysis Global Market Revenue, by Process of Application, (2019-2027) ($Mn)
Table 35 Cellular Processes Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 36 Signal Transduction Pathway Global Market Revenue, by Region (2019-2027) ($Mn)
Table 37 Circulating Tumor Cells Global Market Revenue, by Region (2019-2027) ($Mn)
Table 38 Single-Cell Analysis Global Market Revenue, by Region (2019-2027) ($Mn)
Table 39 Epigenetic Target Analysis Global Market Revenue, by Region (2019-2027) ($Mn)
Table 40 Subpopulation Characterization Global Market Revenue, by Region (2019-2027) ($Mn)
Table 41 Drug and Candidate Screening Global Market Revenue, by Region (2019-2027) ($Mn)
Table 42 Cell Analysis Global Market Revenue, by Field of Application, (2019-2027) ($Mn)
Table 43 Forensics Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 44 Therapeutics Global Market Revenue, by Region (2019-2027) ($Mn)
Table 45 Genomic Analysis Global Market Revenue, by Region (2019-2027) ($Mn)
Table 46 Stem Cell Analysis Global Market Revenue, by Region (2019-2027) ($Mn)
Table 47 Biomarker Research Global Market Revenue, by Region (2019-2027) ($Mn)
Table 48 Cell Imaging Global Market Revenue, by Region (2019-2027) ($Mn)
Table 49 Live Cell Imaging Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 50 Diagnostics Global Market Revenue, by Region (2019-2027) ($Mn)
Table 51 Cell Analysis Global Market Revenue, by Therapeutic Area of Application, (2019-2027) ($Mn)
Table 52 Cancer Research Global Market Revenue by Region, (2019-2027) ($Mn)
Table 53 Genetic Testing Global Market Revenue, by Region (2019-2027) ($Mn)
Table 54 Infectious Diseases Global Market Revenue, by Region (2019-2027) ($Mn)
Table 55 Immunology Global Market Revenue, by Region (2019-2027) ($Mn)
Table 56 Other Therapeutics Global Market Revenue, by Region (2019-2027) ($Mn)
Table 57 Cell Analysis Global Market Revenue, by End-Users, (2019-2027) ($Mn)
Table 58 Hospitals and Diagnostic Laboratories Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 59 Academic & Research Laboratories Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 60 Pharma & Biotech Companies Global Market Revenue by Region, (2019-2027) ($Mn)
Table 61 CRO’s Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 62 Cell Banks Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 63 Other End-Users Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 64 Cell Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 65 North America Cell Analysis Market Revenue, by Technique,(2019-2027) ($Mn)
Table 66 North America Cell Analysis Market Revenue, by Products, (2019-2027) ($Mn)
Table 67 North America Cell Analysis Market Revenue, by Consumables, (2019-2027) ($Mn)
Table 68 North America Cell Analysis Market Revenue, by Instruments, (2019-2027) ($Mn)
Table 69 North America Cell Analysis Market Revenue, by Process of Application, (2019-2027) ($Mn)
Table 70 North America Cell Analysis Market Revenue, by Field of Application, (2019-2027) ($Mn)
Table 71 North America Cell Analysis Market Revenue, by Therapeutic Area of Application, (2019-2027) ($Mn)
Table 72 North America Cell Analysis Market Revenue, by End-User, (2019-2027) ($Mn)
Table 73 North America Cell Analysis Market Revenue, by Country, (2019-2027) ($Mn)
Table 74 Europe Cell Analysis Market Revenue, by Technique,(2019-2027) ($Mn)
Table 75 Europe Cell Analysis Market Revenue, by Products, (2019-2027) ($Mn)
Table 76 Europe Cell Analysis Market Revenue, by Consumables, (2019-2027) ($Mn)
Table 77 Europe Cell Analysis Market Revenue, by Instruments, (2019-2027) ($Mn)
Table 78 Europe Cell Analysis Market Revenue, by Process of Application, (2019-2027) ($Mn)
Table 79 Europe Cell Analysis Market Revenue, by Field of Application, (2019-2027) ($Mn)
Table 80 Europe Cell Analysis Market Revenue, by Therapeutic Area of Application, (2019-2027) ($Mn)
Table 81 Europe Cell Analysis Market Revenue, by End-User, (2019-2027) ($Mn)
Table 82 Europe Cell Analysis Market Revenue, by Country, (2019-2027) ($Mn)
Table 83 APAC Cell Analysis Market Revenue, by Technique,(2019-2027) ($Mn)
Table 84 APAC Cell Analysis Market Revenue, by Products, (2019-2027) ($Mn)
Table 85 APAC Cell Analysis Market Revenue, by Consumables, (2019-2027) ($Mn)
Table 86 APAC Cell Analysis Market Revenue, by Instruments, (2019-2027) ($Mn)
Table 87 APAC Cell Analysis Market Revenue, by Process of Application, (2019-2027) ($Mn)
Table 88 APAC Cell Analysis Market Revenue, by Field of Application, (2019-2027) ($Mn)
Table 89 APAC Cell Analysis Market Revenue, by Therapeutic Area of Application, (2019-2027) ($Mn)
Table 90 APAC Cell Analysis Market Revenue, by End-User, (2019-2027) ($Mn)
Table 91 APAC Cell Analysis Market Revenue, by Country, (2019-2027) ($Mn)
Table 92 ROW Cell Analysis Market Revenue, by Technique, (2019-2027) ($Mn)
Table 93 ROW Cell Analysis Market Revenue, by Products, (2019-2027) ($Mn)
Table 94 ROW Cell Analysis Market Revenue, by Consumables, (2019-2027) ($Mn)
Table 95 ROW Cell Analysis Market Revenue, by Instruments, (2019-2027) ($Mn)
Table 96 ROW Cell Analysis Market Revenue, by Process of Application, (2019-2027) ($Mn)
Table 97 ROW Cell Analysis Market Revenue, by Field of Application, (2019-2027)($Mn)
Table 98 ROW Cell Analysis Market Revenue, by Therapeutic Area of Application, (2019-2027) ($Mn)
Table 99 ROW Cell Analysis Market Revenue, by End-User, (2019-2027) ($Mn)
Table 100 ROW Cell Analysis Market Revenue, by Country, (2019-2027) ($Mn)
Table 101 New Product Launch (2019-2020)
Table 102 Approvals (2019-2020)
Table 103 Agreements, Partnerships and Collaborations (2019-2020)
Table 104 Acquisitions (2019-2020)
Table 105 Others (2019-2020)
Table 106 Agilent Technologies, Inc.: Total Revenue and R&D Expenses, (2018-2020) ($Mn)
Table 107 Agilent Technologies, Inc.: Total Revenue by Segment, (2018-2020) ($Mn)
Table 108 Agilent Technologies, Inc.: Total Revenue, by Region, (2018-2020) ($Mn)
Table 109 Becton Dickinson and Company: Total Revenue and R&D Expenses, (2018-2020)($Mn)
Table 110 Becton Dickinson and Company: Total Revenue by Segment, (2018-2020) ($Mn)
Table 111 Becton Dickinson and Company: Life Sciences Revenue by Sub - Segment, (2018-2020) ($Mn)
Table 112 Becton Dickinson and Company: Total Revenue, by Region, (2018-2020) ($Mn)
Table 113 Bio-Rad Laboratories, Inc: Total Revenue and R&D Expenses, (2018-2020)(Q3) ($Mn)
Table 114 Bio-Rad Laboratories: Total Revenue by Segment, (2018-2020) (Q3) ($Mn)
Table 115 Bio-Rad Laboratories: Total Revenue, by Region, (2018-2020) (Q3) ($Mn)
Table 116 Danaher Corporation: Total Revenue and R&D Expenses (2018-2020) (Q3) ($Mn)
Table 117 Danaher Corporation: Total Revenue, by Segment, (2018-2020)(Q3) ($Mn)
Table 118 Danaher Corporation: Total Revenue, by Region, (2018-2020) (Q3) ($Mn)
Table 119 Illumina, Inc.: Total Revenue and R&D Expenses, (2018-2020) (Q3) ($Mn)
Table 120 Illumina, Inc.: Total Revenue, by Geography, (2018-2020)(Q3) ($Mn)
Table 121 Merck Kgaa: Total Revenue and R&D Expenses, (2018-2020) (Q3) ($Mn)
Table 122 Merck Kgaa: Total Revenue, by Segment, (2018-2020) (Q3) ($Mn)
Table 123 Merck Kgaa Company: Total Revenue, by Life-Science Sub-Segments, (2018-2020) (Q3) ($Mn)
Table 124 Merck Kgaa Company: Total Revenue, by Geography, (2018-2020) (Q3) ($Mn)
Table 125 Olympus Corporation: Total Revenue and R&D Expenses, (2019 -2021) (Q2) ($Mn)
Table 126 Olympus Corporation: Total Revenue by Segment, (2019-2021) (Q2) ($Mn)
Table 127 Olympus Corporation: Total Revenue by Geography, (2019-2021)(Q2) ($Mn)
Table 128 Perkinelmer, Inc.: Total Revenue and R&D Expenses, (2018-2020) (Q3) ($Mn)
Table 129 Perkinelmer, Inc.: Total Revenue by Segment, (2018-2020) (Q3) ($Mn)
Table 130 Perkinelmer, Inc.: Total Revenue, by Region, (2018-2020) (Q3) ($Mn)
Table 131 Qiagen N.V.: Total Revenue and R&D Expenses, (2018 -2020) (Q3) ($Mn)
Table 132 Qiagen N.V.: Total Revenue by Segment, (2018-2020)(Q3) ($Mn)
Table 133 Qiagen N.V.: Total Revenue, by Region, (2018-2020) (Q3)($Mn)
Table 134 Thermo Fisher Scientific, Inc.: Total Revenue and R&D Expenses, (2018-2020) (Q3) ($Mn)
Table 135 Thermo Fisher Scientific, Inc.: Total Revenue, by Segment, (2018-2020) (Q3) ($Mn)
Table 136 Thermo Fisher Scientific, Inc.: Total Revenue, by Geography, (2018-2020)(Q3) ($Mn)
List of Figures
Figure 1 Cell Analysis Global Market Revenue, by Geography (2019-2027)($Mn)
Figure 2 Research Methodology: Cell Analysis Global Market
Figure 3 Cell Analysis Global Market: Top-Down and Bottom-Up Approach
Figure 4 Cell Analysis Global Market: Forecasting Model
Figure 5 Cell Analysis Global Market: Market Breakdown & Data Triangulation
Figure 6 Cell Analysis Global Market: Market Segmentation
Figure 7 Market Dynamics
Figure 8 Cell Analysis Global Market: Porter’s Analysis
Figure 9 Cell Analysis Global Market Share Analysis, by Key Players, (2020) (%)
Figure 10 Single-Cell Analysis Global Market Share Analysis, by Key Players, (2020) (%)
Figure 11 Cell Analysis Global Market Share, by Techniques (2020) (%)
Figure 12 Cell Analysis Global Market Share, by Products and Consumables Sub-Segment, (2020) ($Mn)
Figure 13 Cell Analysis Global Market Revenue, by Instruments, (2020 Vs 2027) ($Mn)
Figure 14 Cell Analysis Global Market Share, by Process of Application (2020 V/S 2027) (%)
Figure 15 Cell Analysis Global Market Share, by Field of Application (2020 V/S 2027) (%)
Figure 16 Cell Analysis Global Market Share, by Therapeutic Area of Application (2020 V/S 2027) (%)
Figure 17 Cell Analysis Global Market Share, by End-Users (2020 V/S 2027) (%)
Figure 18 Cell Analysis Market Global Revenue, by Region (2019-2027) ($Mn)
Figure 19 Cell Analysis Global Market Revenue, by Geography (2020) ($Mn)
Figure 20 North America Cell Analysis Market Share, by Technique (2020) (%)
Figure 21 North America Cell Analysis Market Revenue, by Product and Consumables Sub - Segment (2020) ($Mn)
Figure 22 North America Cell Analysis Market Revenue, by Instruments (2020 Vs 2027) ($Mn)
Figure 23 North America Cell Analysis Market Share, by Process of Application (2020 V/S 2027) (%)
Figure 24 North America Cell Analysis Market Share, by Field of Application (2020 V/S 2027) (%)
Figure 25 North America Cell Analysis Market Share, by Therapeutic Area of Application (2020 V/S 2027) (%)
Figure 26 North America Cell Analysis Market Share, by End-User (2020 V/S 2027) (%)
Figure 27 North America Cell Analysis Market Share, by Country (2020 V/S 2027) (%)
Figure 28 U.S Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 29 U.S. Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 30 U.S. Cell Analysis Application Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 31 Rest of North America Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 32 Rest of North America Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 33 Rest of North America Cell Analysis Market Revenue, by End-User (2020 Vs 2027) ($Mn)
Figure 34 Europe Cell Analysis Market Share, by Technique (2020) (%)
Figure 35 Europe Cell Analysis Market Revenue, by Products and Consumables Sub-Segment (2020) ($Mn)
Figure 36 Europe Cell Analysis Market Revenue, by Instruments (2020 V/S 2027) ($Mn)
Figure 37 Europe Cell Analysis Market Share, by Process of Application (2020 V/S 2027) (%)
Figure 38 Europe Cell Analysis Market Share, by Field of Application (2020 V/S 2027) (%)
Figure 39 Europe Cell Analysis Market Share, by Therapeutic Area Application (2020 V/S 2027) (%)
Figure 40 Europe Cell Analysis Market Share, by End-User (2020 V/S 2027) (%)
Figure 41 Europe Cell Analysis Market Share, by Country (2020 V/S 2027) (%)
Figure 42 Germany Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 43 Germany Cell Analysis Market Revenue, by Field of Application (2020 V/S 2027) ($Mn)
Figure 44 Germany Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 45 France Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 46 France Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 47 France Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 48 Italy Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 49 Italy Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 50 Italy Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 51 Rest of Europe Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 52 Rest of Europe Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 53 Rest of Europe Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 54 APAC Cell Analysis Market Share, by Technique (2020) (%)
Figure 55 APAC Cell Analysis Market Revenue, by Products and Consumables Sub-Segment (2020) ($Mn)
Figure 56 APAC Cell Analysis Market Revenue, by Instruments (2020 V/S 2027) ($Mn)
Figure 57 APAC Cell Analysis Market Share, by Process of Application (2020 V/S 2027) (%)
Figure 58 APAC Cell Analysis Market Share, by Field of Application (2020 V/S 2027) (%)
Figure 59 APAC Cell Analysis Market Share, by Therapeutic Area of Application (2020 V/S 2027) (%)
Figure 60 APAC Cell Analysis Market Share, by End-User (2020 V/S 2027) (%)
Figure 61 APAC Cell Analysis Market Share, by Country (2020 V/S 2027) (%)
Figure 62 Japan Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 63 Japan Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 64 Japan Cell Analysis Market Revenue, by End-User (2020 Vs 2027) ($Mn)
Figure 65 China Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 66 China Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 67 China Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 68 India Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 69 India Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 70 India Cell Analysis Market Revenue, by End-User (2020 Vs 2027) ($Mn)
Figure 71 Rest of APAC Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 72 Rest of APAC Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 73 Rest of APAC Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 74 Rest of the World Cell Analysis Market Share, by Technique (2020) (%)
Figure 75 Rest of the World Cell Analysis Market Share, by Products and Consumables Sub-Segment (2020) ($Mn)
Figure 76 Rest of the World Cell Analysis Market Revenue, by Instruments (2020 V/S 2027) ($Mn)
Figure 77 Rest of the World Cell Analysis Market Share, by Process of Application (2020 V/S 2027) (%)
Figure 78 Rest of the World Cell Analysis Market Share, by Field of Application (2020 V/S 2027) (%)
Figure 79 Rest of the World Cell Analysis Market Share, by Therapeutic Area Application (2020 V/S 2027) (%)
Figure 80 Rest of the World Cell Analysis Market Share, by End-User (2020 V/S 2027) (%)
Figure 81 Rest of the World Cell Analysis Market Share, by Country (2020 V/S 2027) (%)
Figure 82 Brazil Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 83 Brazil Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 84 Brazil Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 85 Rest of Latam Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 86 Rest of Latam Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 87 Rest of Latam Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 88 Middle East and Africa Cell Analysis Market Revenue, by Products, Process of Application (2020 V/S 2027) ($Mn)
Figure 89 Middle East and Africa Cell Analysis Market Revenue, by Field of Application, Therapeutic Area of Application (2020 V/S 2027) ($Mn)
Figure 90 Middle East and Africa Cell Analysis Market Revenue, by End-User (2020 V/S 2027) ($Mn)
Figure 91 Key Growth Strategies (2019-2020)
Figure 92 SWOT: Agilent Technologies
Figure 93 SWOT: Becton Dickinson and Company
Figure 94 SWOT: Bio-Rad Laboratories Inc.
Figure 95 SWOT: Danaher Corporation
Figure 96 SWOT: Illumina Inc.
Figure 97 SWOT: Merck Kgaa
Figure 98 SWOT: Olympus Corporation
Figure 99 SWOT: Perkinelmer, Inc
Figure 100 SWOT: Promega Corporation
Figure 101 SWOT: Qiagen N V
Figure 102 SWOT: Thermo Fisher Scientific
LOADING...
- 1Cellbio
- 10X Genomics
- 23Andme
- Andreas Hettich GmbH & Co. Kg
- Abbexa Ltd
- Abcam plc.
- Abdos Labtech Pvt, Ltd.
- Abnova Corporation
- ABP Biosciences LLC
- Agilent Technologies Inc.
- Akadeum Life Sciences
- Alit Lifesciences Co. Ltd
- Altona Diagnostics GmbH
- Analytik Jena AG
- Art Robbins Instruments LLC
- Aelian Biotechnology
- Abbott Laboratories, Inc.
- Aviva Bioscience
- Arraygen Technologies Pvt Ltd
- Ancestry Health
- Becton Dickinson and Company
- Bio View Ltd.
- Bio X Cell
- Biochrom Ltd.
- BGI Group
- Biofluidica
- Bitbiome, Inc.
- Bio-Rad Laboratories Inc.
- Bioingentech
- Bioneer Corporation
- Bioron GmbH
- Bio-Techne Corporation
- Blue-Ray Biotech
- Brand GmbH
- Brooks Life Sciences
- Bruker Corporation
- Bennubio Inc.
- Bioskryb, Inc.
- Bioagilytix Labs, LLC
- Berry Genomics Co. Ltd
- Cleaver Scientific
- Capp Aps
- Cegat GmbH
- Carl Zeiss AG
- Cell Signaling Technology, Inc.
- Celltool
- Cherry Biotech
- Celsius Therapeutics
- Cytosmart Technologies B.V.
- Cytek Biosciences
- Cell Microsystems
- Cellink
- Celtic Molecular Diagnostics
- Capitalbio Corporation
- Cell Biolabs, Inc.
- Corning Inc.
- DA AN Gene Co. Ltd.
- Danaher Corporation
- Denovix Inc.
- Diagenode Sa
- Deepcell
- Dlab Scientific Co. Ltd.
- Dolomite Bio
- Emedgene Technologies Ltd
- Enzo Life Sciences Inc.
- Epigenomics AG
- Eppendorf
- Etaluma Inc.
- Eurofins Scientific
- Fluidigm Corporation
- Fluxion Biosciences
- Genomatix AG
- Genxpro GmbH (Germany
- Hamilton Company
- Hausser Scientific
- Herolab GmbH
- Hettich Lab Technology
- Horiba, Ltd
- Highqu GmbH
- Incelldx
- Inscopix
- Illumina Inc.
- Isoplexis
- Jasco Analytical Instruments
- Jeol Ltd
- Kromatid
- Keyence Corporation
- Kyratec
- Helena Laboratories Corporation
- Labgene Scientific Sa
- Lgc Ltd (Biosearch Technologies)
- Lucigen Corporation
- Luminex Corporation
- Lunglife Ai, Inc
- Lonza Group
- LW Scientific
- Meiji Techno Co. Ltd
- Merck Kgaa
- Micro-Shot Technology Ltd.
- Miltenyil Biotec GmbH
- Mission Bio, Inc.
- Menarini Silicon Biosystems
- Macrogen Inc
- Nanolive Sa
- Novogene Co. Ltd
- Nanostring Technologies
- Namocell Inc.
- Nikon Corporation
- Nexcelom Bioscience
- Nebula Genomics
- Optika Srl
- Olympus Corporation
- Oxford Nanopore Technologies, Ltd.
- Paradigm4
- Perkinelmer
- Picoquant GmbH
- Promega Corporation
- Promocell
- Pacific Biosciences
- Proteona Pte. Ltd.
- Qiagen N.V
- Quest Diagnostics
- Renishaw plc
- Roche Diagnostics
- Rarecyte, Inc
- Singleron Biotechnologies. Inc
- Sartorius AG
- Shimadzu Corporation
- Sinaclon
- Single-Cell Discoveries
- Sony Biotechnology
- Sphere Fluidics
- Scailyte AG
- Stemcell Technologies
- Sysmex Coperation
- Scipio Bioscience S.A.S
- S2 Genomics, Inc.
- Thermo Fisher Scientific
- Thinkcyte
- Tecan Group Ltd.
- Tomocube Inc.
- Takara Bio
- Visitron Systems GmbH
- Vizgen, Inc.
- Yokogawa Electric Corporation
- Zymo Research
